Prudent Small Cap Portfolio

Quantitative Portfolio Targeting Small Caps

The Secret of Getting Ahead is Getting Started ... Mark Twain

2022 (NOV 1)           GA SMALL CAP  - 31 %         RUSSELL 2000  - 18%
2021                  GA SMALL CAP  + 29%          RUSSELL 2000  + 13%
2020                   GA SMALL CAP  + 87%          RUSSELL 2000  + 18%
2019                   GA SMALL CAP  + 27%          RUSSELL 2000  + 25%

jump down to Pricing & Sign Up
Prudent Small Cap ~ Description

The Prudent Small Cap (formerly Graycell Small Cap) portfolio focuses on the universe of stocks from $200 million to $3 billion in market capitalization. The portfolio investment focus is to participate in the early stages of the growth of a company while diversifying sufficiently across a market cap range that includes even early stage midcap or SMID (small midcap) companies. The return objective of the quantitative model driven portfolio is to outperform the Russell 2000 by at least 5% points over a 12-month period. As you will observe from the long history, the model portfolio performance has surpassed its objective quite convincingly. The model portfolio comprises up to 10 almost equally-weighted stocks. The year 2018 is the 14th year the publication has been open to subscribers.

  • The Enduring Power of Small Cap Stocks
    The Power of Compounding
    Growth of a Single Dollar from 1926 through 2018

Graycell Advisors ~ Stock Market Performance, Small Cap and Large Cap Performance - 1926 onwards ~ Morningstar

Growth of $1 In Stocks, Bonds, Bills and Inflation ~ 1926 onwards ~ Source: MorningStar / Ibbotson Associates / NY Life

Growth of $1 In Stocks, Bonds, Bills, & Inflation ~ 1926 to 2021 ~ Morningstar / Ibbotson / NY Life

(hypothetical $1, assumes reinvestment of income and no taxes & transaction costs)

  • Investment Focus

    The Small Cap Model Portfolio Newsletter focuses on young and emerging companies.

    Small cap stocks are typically more risky, in terms of measures of dispersion like standard deviation or volatility, than larger-cap stocks. The risk in this segment is a combination of many factors including relatively¬†less liquidity or volume of shares traded, lesser research-coverage¬†compared to their larger cap peers, greater sensitivity to unconfirmed market rumors or hearsay, and less well capitalized along with relatively limited access to¬†financing options. However, the greatest opportunities for capital appreciation also lie in the small cap and early stage midcap stocks, principally because of their undiscovered nature. The key is to manage down the risk, since it can’t be eliminated, and find a balanced blend of risk and reward for that asset class. Our philosophy and systematic investing approach apply to all our products.

    Small caps are generally defined as stocks with a market capitalization (market cap) between $200 million and $2 billion. We believe a wider investing definition that includes SMID or smaller midcap companies, which are relatively more stable, can contribute towards managing down risk and enhancing risk-adjusted returns. Consequently, the Graycell Small Cap Model Portfolio has a targeted market cap range of $200 million to $3 billion.

    The¬†focus for the model portfolio is on generating¬†consistent and strong returns, and we achieve that through our¬†highly disciplined approach to investing. It’s a multi-dimensional approach combining a number of aspects including process-orientation, market direction analysis, and¬†experience-and-rules-driven quantitative modeling and using fundamental and technical variables.

    Delivering strong annual returns exceeding benchmark, will be considered quite satisfactory to many investors. However, overlaid on this investing approach is our belief in the Power of Compounding. It is this blend of strong returns further powered by compounding that delivers incredible portfolio growth over the long-term. Investors must use the enduring power of the markets and the magic of compounding to build long term wealth.

Would You Like A FREE Monthly Small Cap Pick?

A pick from the small cap portfolio delivered to your mailbox for the next 12 months

We value your privacy and would never share

  • Performance


    The Graycell Small Cap Model Portfolio was first offered in 2003 as a weekly newsletter. It was available for 7-years till 2009 and was then resumed in 2012 for 4 years till 2015. Since 2016, the portfolio is offered as a monthly newsletter service.

    Over the 11-year period through 2015, the Small Cap Portfolio strongly outperformed the market in all years except one. In addition, the portfolio consistently gained each year.

    The statistics below show the actual performance of the model portfolio holdings published over the period and not back-tested performance. All returns are based on cash equity, and no margin or any form of leverage is used in any of the model portfolios. The cumulative performance chart shows values at the end of the period, and is not a continuous running chart, which makes it appear smoothed. Between the periods there could have been dips, even though the portfolio grew for the period.

    The performance is considered hypothetical, since actual trades were not executed in an audited account, and is presented for illustrative purposes only. No representation is being made that a subscriber will or is likely to achieve profits or losses similar to those shown. Past performance is not indicative of future results, which may vary.


2021 Performance

Prudent Small Cap - Monthly Performance ~ Graycell Advisors

plot of month end values

shadow-ornament ~ Performance - Sharpe Ratio and Standard Deviation

Prudent Small Cap Published Performance

Small Cap Performance 2013 - 2020 ~ Graycell Advisors

Cumulative Performance of Prudent Small Cap

Small Cap Performance 2003 - 2021 ~ Graycell Advisors

(smoothed chart - values at the end of each period)

Small Cap Performance 2012 - 2018 ~ Graycell Advisors

Building Investment Wealth Over Time


Using Systematic Model Investing For Consistent Performance

And It's Repeatable with Discipline and Patience

Why Wait?

a journey from $10,000 to $4 million and still going....

$10,000 Investment - 2003 - 2019 ~ Graycell Advisors
  • Investment Characteristics


    • High Risk and¬†High Reward product
    • Generally appropriate for younger investors who are in their twenties to¬†forties with a long-term focus, who decide to allocate a portion of their portfolio to higher risk opportunities
    • Investors who are in their early fifties should generally¬†consider a relatively smaller allocation to riskier products targeting small cap stocks, while older investors need¬†to determine if small cap sector exposure is beneficial to their investment plans
    • An investor¬†must have at least a 2-3 year horizon to benefit from such systematic¬†portfolio¬†products with an outlook to build investment wealth over time. The most important thing is to have reasonable and realistic expectations from the stock market, which is a risk-reward and not a risk-free market.¬†The small cap portfolio is not insulated against losses, and we can try to manage risk but not eliminate it. Past performance is not indicative¬†of future results.
    • We share our model portfolio through the newsletter subscription but are in no position to comment on the suitability of the product relative to your needs, risk tolerance and financial position. Always consult your professional financial advisor. We are not registered representatives.
  • What Do I Get From The Subscription?

What you get is the Graycell Small Cap Model Portfolio with a complete investing game plan behind it. An investing plan, which has outperformed benchmarks over an entire economic cycle.

Each month when the Graycell Small Cap Portfolio newsletter is available to you, the portfolio you access is not just names of up to 10-stocks. This portfolio of 10-stocks represents an investment game plan driven by quantitative models. Based on your determination of the relevance of this information to your situation, you will now have the ability to use a systematic investing approach to invest in the market.

  • Benefit 1 - A systematic investing approach to follow monthly
  • Benefit 2 - A game plan to follow a quantitative investment strategy
  • Benefit 3 - An emotionless investing system that avoids the judgment risks of experts and humans
  • Benefit 4 - Exposure to the promising names within the high potential smallcap segment
  • Benefit 5 - A diversified portfolio to manage a portion of the stock-specific risk
  • Benefit 6 - Limit risk from prolonged adverse market conditions by knowing when the portfolio is in Cash
  • Benefit 7 - Clear cut updates, simple to understand and follow typically once a month
  • Benefit 8 - No daily decision-making or spending endless hours reading research and remaining undecided
  • Benefit 9 - Once you determine the information is relevant, track the portfolio once-a-month
  • Benefit 10 - Instant access to a quantitative model, for a price of ~$30/month that is less than a dinner check
  • Building Investment Wealth Over Time...


"The Best Time to Plant an Oak was 20 Years Ago.
The Next Best Time is Now..."

How powerful is this old English proverb. You've to start somewhere, sometime.
There is no guarantee of future performance. Nonetheless, it should still be noted that various studies and scholars have provided empirical evidence that bolsters the thesis that systems outsmart individuals consistently. We hope you read our section on Systematic Investing that underlies our approach across all newsletters.

If you feel our system can help grow your portfolio wealth over time, then don't wait!

The Decision is Yours Now!

We leave you with a quote from Warren Buffett,

Warren Buffett

While there is no one best system, there is one that works best for you. Once you choose a system, you need to stick with it.

Warren Buffett, Legendary Investor

Buffett made the above comment while referring to the card game of Bridge. But his words hold a vital truth for Investing as well.

Thanks for reading, and Good Luck!

We wanted to express our thanks. The newsletter reduces all our investing work, and I can never claim to have performed so well in the markets before with much less effort and stress. Thanks for putting a spark in our stock investments.

Roxanne and Albert Weinstein, California

My investing has benefited a lot. I'd come to your site after reading about you in Seeking Alpha. But I was a skeptic since I've been burnt many times using all kinds of programs. Thankfully, the results converted me. I don't have to constantly keep tracking my portfolio.

Chad Barthow, New Jersey
  • Pricing

money back logo

Risk Free, 60 Days Money Back Guarantee

We will do our best to provide you with an excellent product to contribute towards your wealth-building goals through disciplined investing. We back this with our guarantee that if you are unsatisfied for any reason with the subscription, you can cancel at any time within 60-days of your Payment for a full refund. No questions asked. So you have 60-days to make up your mind without refund worries and see if the product can contribute to your financial goals. After 60-days, no full, partial or pro-rated refunds are done.

A Good Deal!
$299for 6 months

    ~$41 / month

    Less than a Cable Bill

    No Automatic Renewal

    The Best Deal!
    $699for 2 years (price protection)

      ~$29 / month

      Less than a Water Bill

      No Automatic Renewal

      • 1.Accept
      • 2.Select & Pay
      • 3.Register & Access

      You may view this information in full page format here.

      This Agreement describes your rights and responsibilities with respect to your access to and use of this website, as well as information about the newsletter. Please read this entire agreement carefully before using our website. Your subscription will assume you have read and will comply with the agreement.

      1. Terms and Conditions of Service (TCS). Graycell Advisors (together with its affiliates and employees referred to herein as ‚ÄúGA‚ÄĚ or "we" or "us") is a publisher of financial and investment commentary and opinions, including, but not limited to subscription-based newsletters, like the Prudent Biotech and Graycell Small Cap newsletters, along with any related publications (‚ÄúNewsletter‚ÄĚ, "Report", "Publication", "Subscription", "Service"). The Newsletter presents companies that comprise our model portfolio. Please carefully read the Terms and Conditions of Service (‚ÄúTCS‚ÄĚ) set forth below. As a condition of using the website and subscription, you agree to the TCS.

      By using the Service, you affirm that you are at least 18 years of age and are not otherwise barred from receiving and using the newsletter under the laws of the United States or other applicable jurisdiction. You also affirm that you are able and competent to enter into this Agreement and to abide by and comply with the TCS. In addition, you will not use the content on the website or our name and server to violate any US or international laws, including copyright and spamming.

      2. Responsibility. You alone are responsible for your own investment decisions. The information contained herein does not constitute a personal recommendation or takes into account the particular investment objectives, financial situations, or needs of individual investors. Subscribers and investors should always conduct their own due diligence with any potential investment. You should independently verify all information contained in the Newsletter, and on our website(s), and consider obtaining professional advice before making any investment decision.

      3. Risk. All stock investments carry a degree of risk. By investing in any of the stocks of the companies profiled or mentioned in the Newsletter, etc., you can and may lose some or all of your investment. Do not invest in any stock if you are not prepared to lose your entire investment. We are not liable nor do we assume any responsibility for losses incurred as a result of any information provided or not provided or not made available in a timely manner, herein or on our website or through any other medium. In addition, we do not guarantee accuracy and completeness of any information furnished by us. Even following all our suggestions will not assure positive results.

      4. Volatility. Stocks are volatile. Biotech and small cap segments are even more volatile due to the nature of the industry and the group. Significant monthly volatility should be expected based on market conditions. In the case of an industry newsletter, like biotech, there is a significant additional risk from one-industry exposure, as would be true for any industry focused portfolio or fund. A concentrated portfolio of 8-or-10-holdings will have greater up-and-down volatility than the same industry fund or an industry index, like the Nasdaq Biotechnology Index or the small cap Russell 2000 index, with more holdings.

      5. Performance. Past performance is no guarantee of future success and you should not assume that the performance of our model portfolio in the future will meet or exceed the model's historical performance. Historical performance figures and analysis provided are hypothetical, unaudited, and prepared by us, based on our proprietary analysis and system performance. Performance prior to the launch of the product was back-tested. No actual trades have taken place. The performance results obtained are intended for illustrative purposes only, and although we believe the results to be accurate, we cannot guarantee it and they have not been independently verified.

      6. Non-Advisor. We are not a registered investment advisor, also known as RIA, and nothing contained in any materials should be construed as a recommendation to buy or sell securities.

      7. Member Portfolio Results. Actual performance results achieved by members will differ by some measure from results reported for the portfolio for various reasons, including, without limitation:
      - model portfolio performance results do not reÔ¨āect trading commissions and exchange fees
      - model portfolio performance results do not account for the impact, if any, of certain market factors, such as lack of liquidity, to initiate or close positions, that may affect results
      - model portfolio positions are opened and closed at the opening prices on the first trading day after the publication of the newsletter. Such prices may not be available, and could be better or worse, at the time trades are placed by members
      - model portfolio prices are recorded at the beginning of the month while members may join at any time during the month, at which time prices may be different - higher or lower

      8. Existing Positions. We may or may not have existing positions in the stocks mentioned in the newsletter, prior to the dissemination of the newsletter. We do not favor any subscriber of a product, and a bulk alert is sent to all subscribers via email once the newsletter is available in the Members Area.

      9. Models. Our models are proprietary and/or licensed. We can change the models at any time without any notification. The historical performance will change anytime a revision occurs.

      10. Registration Information. You are responsible for keeping your information updated, particularly the email address. An update can be done by clicking on the Edit Profile button on the Members Home Page.

      11. Your Right to Receive an Issue. Based on the product feature, you are entitled to a monthly issue over the duration of your subscription. In the case of monthly publications, there are 12 issues published in a single year. In the event that we are unable to publish the newsletter within 50 days of the prior issue or terminate its dissemination, you will be entitled to a refund based on the number of unused months remaining on your subscription. This refund is not affected by any limit for the money-back guarantee. No interest will be provided on any refunds.

      12. Your Responsibility to Not Share the Subscription. You are purchasing or have purchased a subscription for yourself. You agree not to share this newsletter with other investors or with institutions, with the intent of sharing information to avoid a subscription. In other words, one subscription for one investor. The standard industry practice of IP capturing is done upon login. Please avoid sharing this newsletter with non-subscribers, so you can receive the best entry prices and outcomes. By simply forwarding or sharing the newsletter to unpaid subscribers, you hurt our ability to monetize our work. Such a situation can lead to closing the product, which hurts all subscribers. In case of an unfortunate event of a violation, we can cancel the subscription at our discretion with no refund, if you are beyond the limit for the money-back guarantee.

      13. Refunds. You can cancel at any time within the refund period, presently 60-days from your payment, for a full refund. So you have 60-days to make up your mind without refund worries and see if the product can contribute to your goals. After 60-days, no full, partial or pro-rated refunds will be done. Please note, the refund guarantee period is only for first-time subscribers.

      14. Renewals. We do not automatically renew. To avoid service interruption, a subscription renewal has to be done prior to its expiration. Such renewals can take place at any time and you don't have to wait for the last month. Simply login and then go to either the Sign Up page or click on Renewal button on the Members Page, and choose your subscription length to renew. You will receive email alerts periodically as you approach the end date. There are no refunds on Renewals.

      15. Dispute. In any dispute, and where any of the limitations or disclaimers are ineffective or inapplicable, you agree that our maximum liability will be the amount of money remaining on your unused full months of subscription.

      16. Resubscribing to Avoid Payment is Prohibited. You agree Not to re-subscribe multiple times to the same Newsletter and then request multiple refunds, or register for multiple subscriptions to the same newsletter under different email addresses in order to avoid paying the subscription price. This is a violation and no refund will be issued for any portion even if you are within the refund period. Please note, the refund guarantee period is only for the first time new subscribers.

      17. No-risk Subscription Offer. The offer to refund your subscription within a specific period cannot be used again within a 6-month period from the date of the Refund. After your first Sign Up, if you decide to cancel and receive a refund, you may NOT Sign Up again within the 6-month duration and expect the same refund period offer; instead, your Sign Up will no longer be covered by the refund offer, and you cannot request a refund.

      18. Our Right of Cancellation. We have the right to not accept your subscription or discontinue it at any time during the subscription period without offering a reason. We may terminate your access to the Newsletter and the Website at any time at our sole discretion. In such situations, we will provide a pro rata monthly refund for any paid subscription. However, if we terminate your access to the Service because you have violated any provision of the TCS, including without limitation by seeking to register and cancel multiple times in an effort to secure access to a paid subscription without paying applicable subscription fees or making slanderous comments on public forums, etc., you will Not be entitled to receive a refund of any portion of the subscription fee paid by you.

      19. Your Right of Cancellation. You may choose to cancel at any point. If your cancellation request is within the money-back guarantee period, you shall receive a full refund of the paid amount. If the request falls after the money-back guarantee period, you will not be refunded any amount and will lose your membership access. In such a situation, a better alternative for you can be to let the subscription expire at the end of the period and not renew while retaining your access to the subscription.

      20. User Code of Conduct. You agree Not to do any of the following:
      - use the Service for any unlawful purpose
      - permit anyone else whose account or subscription was terminated or who has not registered or paid for our content to use any portion of our paid newsletter product through your subscription, username or password
      - restrict or inhibit any other visitor or member from using our newsletter
      - engage in hacking, spamming or defacing any portion of any of our website or newsletter
      - ‚Äúframe‚ÄĚ or ‚Äúmirror‚ÄĚ any part of our website(s) without our prior written authorization
      - copy any content without our written permission
      - making slanderous comments about us on public forums or directly to us

      If you have any questions about our Terms of Use, please contact us by filling out the Contact form.


      Yes! Sign me up now for the monthly Graycell Smallcap newsletter.

      (Registration instructions will be sent to the email ID you use with Paypal.

      Please check the Spam folder if you don't see our email in 1-5 minutes after payment)

      Graycell Advisors, and its affiliates, officers, employees, families, and all other related parties, collectively referred to as ‚ÄėGraycell‚Äô and/or ‚Äėwe,‚Äô is a publisher of financial information, such as the Smallcap, and Prudent Biotech newsletters. We are not a Registered Investment Advisor (RIA). Historical performance figures provided are hypothetical and unaudited, and based on our proprietary analysis and system performance, back-tested over an extended period of time. Hypothetical or simulated performance results have limitations, and unlike an actual performance record, simulated results do not represent actual trading and consequently do not involve financial risk of actual trading. The performance results obtained are intended for illustrative purposes only. No representation is being made that an account will or is likely to achieve profit or losses similar to those shown. Past performance is not indicative of future results, which may vary. All stock and related investments have a degree of risk, which can result in a significant or total loss. In addition, biotech sector and smallcaps are characterized by much higher risk and volatility than the general stock market. Information contained herein is general and does not constitute a personal recommendation or takes into account the particular investment objectives, financial situations, or needs of individual investors. If you decide to invest in any of the stocks of the companies mentioned in the newsletters, samples, alerts, etc., sent to you or available on our websites, you can and may lose some or all of your investment. You alone are responsible for your investment decisions. Use of the information herein is at one's own risk. We are simply sharing the results of our model. Nothing should be construed as a recommendation or an offer to buy or sell any securities, and we are not liable nor do we assume any liability or responsibility for losses incurred as a result of any information provided or not provided or not made available in a timely manner, herein or on our website or using any other medium. We cannot guarantee the accuracy and completeness of any information furnished by us. We may or may not have existing positions in the stocks mentioned in our reports. Our models are proprietary and/or licensed, and can be changed or revised based on our discretion at any time without any notification. Subscribers and investors should always conduct their own due diligence with any potential investment, and consider obtaining professional advice before making an investment decision.
      © Graycell Advisors. All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the written permission of Graycell Advisors is strictly prohibited and shall be deemed to be copyright infringement.